TCL Archive In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online February 5, 1999
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups April 18, 1975
TCL Archive In Brief: Leaks From Cooperative Group Site Visits Vex CCIRC; Tumor Cell Cloning Workshop Set August 11, 1978